Teri Guidi is President & CEO of The Oncology Management Consulting Group, an oncology consulting firm that helps practices devise and implement the strategies and processes to remain competitive and solvent.
Before 2005, the Centers for Medicare & Medicaid Services (CMS) reimbursed physicians for drugs administered in their offices at a percentage of the average wholesale price. In 2005, however, the payment basis was changed to a percentage of a newly created measure, the average sales price. This change resulted in a significant change to the bottom line for all physician practices that administered chemotherapy and other infused drugs.
Read Now
Stay up to date with urology news & updates by subscribing to receive the free UPM print publications or e‑Newsletters.